Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MLL3 loss drives metastasis and therapeutic resistance by promoting a hybrid EMT state
PubMed Full text in PMC Similar studies Analyze with GEO2R
MLL3 Loss Drives Metastasis by Promoting a Hybrid Epithelial-Mesenchymal Transition State [ATAC-seq]
PubMed Full text in PMC Similar studies
MLL3 Loss Drives Metastasis by Promoting a Hybrid Epithelial-Mesenchymal Transition State [ChIP-seq UTX and MLL4]
MLL3 Loss Drives Metastasis by Promoting a Hybrid Epithelial-Mesenchymal Transition State [ChIP-seq histone marker]
MLL3 Loss Drives Metastasis by Promoting a Hybrid Epithelial-Mesenchymal Transition State [RNA-seq MDA231 KO vs WT]
MLL3 Loss Drives Metastasis by Promoting a Hybrid Epithelial-Mesenchymal Transition State [RNA-seq EM vs M]
Effect of Mll3 deletion in MCF7 cells
MLL3 loss drives metastasis and therapeutic resistance by promoting a hybrid EMT state [RNA-seq]
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
A complex epigenome-splicing crosstalk governs epithelial to mesenchymal transition in metastasis and brain development
PubMed Similar studies Analyze with GEO2RSRA Run Selector
Single cell RNA sequencing on PyMT mammary gland primary tumor and lung metastases
Single cell RNA sequencing on PyMT mammary gland tumor cells
PubMed Full text in PMC Similar studies SRA Run Selector
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis
Identification of stable markers of the EMT:MET process
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells
WDR5 regulates EMT and metastasis in breast cancer by activating TGFB pathway
WDR5 regulates EMT and metastasis in breast cancer by activating TGFB pathway [RNA-seq PDX]
WDR5 regulates EMT and metastasis in breast cancer by activating TGFB pathway [RNA-seq CCL]
WDR5 regulates EMT and metastasis in breast cancer by activating TGFB pathway [ChIP-seq]
HDAC inhibition impedes epithelial–mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on